nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—PTGS2—lung cancer	0.179	0.54	CbGaD
Pomalidomide—ABCB1—lung cancer	0.152	0.46	CbGaD
Pomalidomide—PTGS2—Cisplatin—lung cancer	0.0301	0.0803	CbGbCtD
Pomalidomide—PTGS2—Etoposide—lung cancer	0.0295	0.0789	CbGbCtD
Pomalidomide—ABCB1—Topotecan—lung cancer	0.0249	0.0665	CbGbCtD
Pomalidomide—ABCB1—Gefitinib—lung cancer	0.0228	0.0608	CbGbCtD
Pomalidomide—ABCB1—Vinorelbine—lung cancer	0.0175	0.0469	CbGbCtD
Pomalidomide—CYP1A2—Erlotinib—lung cancer	0.0154	0.0411	CbGbCtD
Pomalidomide—CYP3A4—Topotecan—lung cancer	0.0149	0.0398	CbGbCtD
Pomalidomide—ABCB1—Crizotinib—lung cancer	0.014	0.0373	CbGbCtD
Pomalidomide—CYP3A4—Gefitinib—lung cancer	0.0136	0.0364	CbGbCtD
Pomalidomide—ABCB1—Gemcitabine—lung cancer	0.0136	0.0364	CbGbCtD
Pomalidomide—ABCB1—Erlotinib—lung cancer	0.0135	0.036	CbGbCtD
Pomalidomide—CYP3A4—Teniposide—lung cancer	0.0132	0.0353	CbGbCtD
Pomalidomide—ABCB1—Paclitaxel—lung cancer	0.0123	0.0329	CbGbCtD
Pomalidomide—ABCB1—Irinotecan—lung cancer	0.0122	0.0325	CbGbCtD
Pomalidomide—CYP1A2—Etoposide—lung cancer	0.0111	0.0298	CbGbCtD
Pomalidomide—ABCB1—Vinblastine—lung cancer	0.0108	0.0289	CbGbCtD
Pomalidomide—CYP3A4—Vinorelbine—lung cancer	0.0105	0.0281	CbGbCtD
Pomalidomide—ABCB1—Cisplatin—lung cancer	0.00992	0.0265	CbGbCtD
Pomalidomide—ABCB1—Etoposide—lung cancer	0.00974	0.026	CbGbCtD
Pomalidomide—ABCB1—Docetaxel—lung cancer	0.00891	0.0238	CbGbCtD
Pomalidomide—CYP3A4—Crizotinib—lung cancer	0.00837	0.0223	CbGbCtD
Pomalidomide—CYP3A4—Erlotinib—lung cancer	0.00807	0.0215	CbGbCtD
Pomalidomide—CYP3A4—Paclitaxel—lung cancer	0.00739	0.0197	CbGbCtD
Pomalidomide—CYP3A4—Irinotecan—lung cancer	0.00729	0.0195	CbGbCtD
Pomalidomide—ABCB1—Doxorubicin—lung cancer	0.00665	0.0177	CbGbCtD
Pomalidomide—CYP3A4—Vinblastine—lung cancer	0.00648	0.0173	CbGbCtD
Pomalidomide—ABCB1—Methotrexate—lung cancer	0.00644	0.0172	CbGbCtD
Pomalidomide—CYP3A4—Etoposide—lung cancer	0.00584	0.0156	CbGbCtD
Pomalidomide—CYP3A4—Docetaxel—lung cancer	0.00534	0.0143	CbGbCtD
Pomalidomide—CYP3A4—Doxorubicin—lung cancer	0.00398	0.0106	CbGbCtD
Pomalidomide—CRBN—respiratory system—lung cancer	0.00126	0.125	CbGeAlD
Pomalidomide—CRBN—bronchus—lung cancer	0.00104	0.103	CbGeAlD
Pomalidomide—TNF—lymph node—lung cancer	0.000961	0.0948	CbGeAlD
Pomalidomide—CRBN—trachea—lung cancer	0.000935	0.0922	CbGeAlD
Pomalidomide—CRBN—cardiac atrium—lung cancer	0.000878	0.0866	CbGeAlD
Pomalidomide—Lenalidomide—PTGS2—lung cancer	0.000814	0.228	CrCbGaD
Pomalidomide—Thalidomide—CYP2E1—lung cancer	0.000791	0.222	CrCbGaD
Pomalidomide—Thalidomide—CYP1A1—lung cancer	0.00078	0.219	CrCbGaD
Pomalidomide—CRBN—bone marrow—lung cancer	0.000741	0.0731	CbGeAlD
Pomalidomide—Lenalidomide—ABCB1—lung cancer	0.000692	0.194	CrCbGaD
Pomalidomide—CRBN—lung—lung cancer	0.000672	0.0663	CbGeAlD
Pomalidomide—Thalidomide—PTGS2—lung cancer	0.000488	0.137	CrCbGaD
Pomalidomide—CRBN—lymph node—lung cancer	0.000459	0.0453	CbGeAlD
Pomalidomide—CYP1A2—respiratory system—lung cancer	0.000416	0.041	CbGeAlD
Pomalidomide—PTGS2—respiratory system—lung cancer	0.000344	0.034	CbGeAlD
Pomalidomide—PTGS2—epithelium—lung cancer	0.000288	0.0284	CbGeAlD
Pomalidomide—PTGS2—bronchus—lung cancer	0.000283	0.028	CbGeAlD
Pomalidomide—PTGS2—trachea—lung cancer	0.000255	0.0251	CbGeAlD
Pomalidomide—CYP1A2—lung—lung cancer	0.000221	0.0218	CbGeAlD
Pomalidomide—ABCB1—respiratory system—lung cancer	0.000213	0.021	CbGeAlD
Pomalidomide—PTGS2—bone marrow—lung cancer	0.000202	0.0199	CbGeAlD
Pomalidomide—PTGS2—lung—lung cancer	0.000183	0.018	CbGeAlD
Pomalidomide—ABCB1—epithelium—lung cancer	0.000178	0.0176	CbGeAlD
Pomalidomide—ABCB1—trachea—lung cancer	0.000157	0.0155	CbGeAlD
Pomalidomide—PTGS2—lymph node—lung cancer	0.000125	0.0123	CbGeAlD
Pomalidomide—ABCB1—bone marrow—lung cancer	0.000125	0.0123	CbGeAlD
Pomalidomide—ABCB1—lung—lung cancer	0.000113	0.0112	CbGeAlD
Pomalidomide—Anxiety—Paclitaxel—lung cancer	9.4e-05	0.000504	CcSEcCtD
Pomalidomide—Malnutrition—Docetaxel—lung cancer	9.39e-05	0.000504	CcSEcCtD
Pomalidomide—Decreased appetite—Gemcitabine—lung cancer	9.39e-05	0.000504	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	9.37e-05	0.000503	CcSEcCtD
Pomalidomide—Nausea—Topotecan—lung cancer	9.33e-05	0.000501	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Gemcitabine—lung cancer	9.32e-05	0.0005	CcSEcCtD
Pomalidomide—Fatigue—Gemcitabine—lung cancer	9.31e-05	0.0005	CcSEcCtD
Pomalidomide—Confusional state—Etoposide—lung cancer	9.3e-05	0.000499	CcSEcCtD
Pomalidomide—Pain—Gemcitabine—lung cancer	9.23e-05	0.000496	CcSEcCtD
Pomalidomide—Constipation—Gemcitabine—lung cancer	9.23e-05	0.000496	CcSEcCtD
Pomalidomide—Nausea—Erlotinib—lung cancer	9.23e-05	0.000496	CcSEcCtD
Pomalidomide—Pancytopenia—Methotrexate—lung cancer	9.22e-05	0.000495	CcSEcCtD
Pomalidomide—Diarrhoea—Vinorelbine—lung cancer	9.2e-05	0.000494	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Cisplatin—lung cancer	9.17e-05	0.000492	CcSEcCtD
Pomalidomide—Infection—Etoposide—lung cancer	9.16e-05	0.000492	CcSEcCtD
Pomalidomide—Feeling abnormal—Irinotecan—lung cancer	9.13e-05	0.00049	CcSEcCtD
Pomalidomide—Confusional state—Paclitaxel—lung cancer	9.12e-05	0.000489	CcSEcCtD
Pomalidomide—Blood creatinine increased—Doxorubicin—lung cancer	9.11e-05	0.000489	CcSEcCtD
Pomalidomide—Back pain—Docetaxel—lung cancer	9.08e-05	0.000488	CcSEcCtD
Pomalidomide—Neutropenia—Methotrexate—lung cancer	9.08e-05	0.000487	CcSEcCtD
Pomalidomide—Dehydration—Doxorubicin—lung cancer	9.05e-05	0.000486	CcSEcCtD
Pomalidomide—Thrombocytopenia—Etoposide—lung cancer	9.03e-05	0.000485	CcSEcCtD
Pomalidomide—Muscle spasms—Docetaxel—lung cancer	9.03e-05	0.000485	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Methotrexate—lung cancer	9.03e-05	0.000485	CcSEcCtD
Pomalidomide—Infection—Paclitaxel—lung cancer	8.98e-05	0.000482	CcSEcCtD
Pomalidomide—Dyspnoea—Cisplatin—lung cancer	8.97e-05	0.000482	CcSEcCtD
Pomalidomide—Skin disorder—Etoposide—lung cancer	8.96e-05	0.000481	CcSEcCtD
Pomalidomide—Dry skin—Doxorubicin—lung cancer	8.92e-05	0.000479	CcSEcCtD
Pomalidomide—Hyperhidrosis—Etoposide—lung cancer	8.91e-05	0.000478	CcSEcCtD
Pomalidomide—Feeling abnormal—Gemcitabine—lung cancer	8.9e-05	0.000478	CcSEcCtD
Pomalidomide—Dizziness—Vinorelbine—lung cancer	8.89e-05	0.000477	CcSEcCtD
Pomalidomide—Nervous system disorder—Paclitaxel—lung cancer	8.87e-05	0.000476	CcSEcCtD
Pomalidomide—Hypokalaemia—Doxorubicin—lung cancer	8.85e-05	0.000475	CcSEcCtD
Pomalidomide—Thrombocytopenia—Paclitaxel—lung cancer	8.85e-05	0.000475	CcSEcCtD
Pomalidomide—Breast disorder—Doxorubicin—lung cancer	8.79e-05	0.000472	CcSEcCtD
Pomalidomide—Skin disorder—Paclitaxel—lung cancer	8.78e-05	0.000471	CcSEcCtD
Pomalidomide—Body temperature increased—Irinotecan—lung cancer	8.76e-05	0.00047	CcSEcCtD
Pomalidomide—Decreased appetite—Cisplatin—lung cancer	8.75e-05	0.00047	CcSEcCtD
Pomalidomide—Hyperhidrosis—Paclitaxel—lung cancer	8.74e-05	0.000469	CcSEcCtD
Pomalidomide—Pneumonia—Methotrexate—lung cancer	8.71e-05	0.000468	CcSEcCtD
Pomalidomide—Nasopharyngitis—Doxorubicin—lung cancer	8.7e-05	0.000467	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Cisplatin—lung cancer	8.69e-05	0.000466	CcSEcCtD
Pomalidomide—Anaemia—Docetaxel—lung cancer	8.68e-05	0.000466	CcSEcCtD
Pomalidomide—Infestation—Methotrexate—lung cancer	8.66e-05	0.000465	CcSEcCtD
Pomalidomide—Infestation NOS—Methotrexate—lung cancer	8.66e-05	0.000465	CcSEcCtD
Pomalidomide—Pain—Cisplatin—lung cancer	8.61e-05	0.000462	CcSEcCtD
Pomalidomide—Alanine aminotransferase increased—Doxorubicin—lung cancer	8.58e-05	0.000461	CcSEcCtD
Pomalidomide—Muscular weakness—Doxorubicin—lung cancer	8.58e-05	0.000461	CcSEcCtD
Pomalidomide—Vomiting—Vinorelbine—lung cancer	8.55e-05	0.000459	CcSEcCtD
Pomalidomide—Body temperature increased—Gemcitabine—lung cancer	8.54e-05	0.000458	CcSEcCtD
Pomalidomide—Renal failure—Methotrexate—lung cancer	8.51e-05	0.000457	CcSEcCtD
Pomalidomide—Rash—Vinorelbine—lung cancer	8.47e-05	0.000455	CcSEcCtD
Pomalidomide—Dermatitis—Vinorelbine—lung cancer	8.47e-05	0.000454	CcSEcCtD
Pomalidomide—Headache—Vinorelbine—lung cancer	8.42e-05	0.000452	CcSEcCtD
Pomalidomide—Leukopenia—Docetaxel—lung cancer	8.4e-05	0.000451	CcSEcCtD
Pomalidomide—Feeling abnormal—Cisplatin—lung cancer	8.29e-05	0.000445	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Paclitaxel—lung cancer	8.24e-05	0.000442	CcSEcCtD
Pomalidomide—Dyspnoea—Etoposide—lung cancer	8.22e-05	0.000441	CcSEcCtD
Pomalidomide—Cough—Docetaxel—lung cancer	8.19e-05	0.00044	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Methotrexate—lung cancer	8.19e-05	0.00044	CcSEcCtD
Pomalidomide—Insomnia—Paclitaxel—lung cancer	8.18e-05	0.000439	CcSEcCtD
Pomalidomide—Epistaxis—Methotrexate—lung cancer	8.17e-05	0.000438	CcSEcCtD
Pomalidomide—Hypersensitivity—Irinotecan—lung cancer	8.17e-05	0.000438	CcSEcCtD
Pomalidomide—Bronchitis—Doxorubicin—lung cancer	8.09e-05	0.000434	CcSEcCtD
Pomalidomide—Dyspnoea—Paclitaxel—lung cancer	8.06e-05	0.000433	CcSEcCtD
Pomalidomide—Decreased appetite—Etoposide—lung cancer	8.01e-05	0.00043	CcSEcCtD
Pomalidomide—Arthralgia—Docetaxel—lung cancer	7.99e-05	0.000429	CcSEcCtD
Pomalidomide—Pancytopenia—Doxorubicin—lung cancer	7.99e-05	0.000429	CcSEcCtD
Pomalidomide—Nausea—Vinorelbine—lung cancer	7.98e-05	0.000429	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Etoposide—lung cancer	7.96e-05	0.000427	CcSEcCtD
Pomalidomide—Body temperature increased—Cisplatin—lung cancer	7.96e-05	0.000427	CcSEcCtD
Pomalidomide—Asthenia—Irinotecan—lung cancer	7.95e-05	0.000427	CcSEcCtD
Pomalidomide—Fatigue—Etoposide—lung cancer	7.95e-05	0.000427	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	7.94e-05	0.000426	CcSEcCtD
Pomalidomide—Pain—Etoposide—lung cancer	7.88e-05	0.000423	CcSEcCtD
Pomalidomide—Constipation—Etoposide—lung cancer	7.88e-05	0.000423	CcSEcCtD
Pomalidomide—Neutropenia—Doxorubicin—lung cancer	7.86e-05	0.000422	CcSEcCtD
Pomalidomide—Decreased appetite—Paclitaxel—lung cancer	7.86e-05	0.000422	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Doxorubicin—lung cancer	7.82e-05	0.00042	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Paclitaxel—lung cancer	7.8e-05	0.000419	CcSEcCtD
Pomalidomide—Fatigue—Paclitaxel—lung cancer	7.79e-05	0.000418	CcSEcCtD
Pomalidomide—Asthenia—Gemcitabine—lung cancer	7.75e-05	0.000416	CcSEcCtD
Pomalidomide—ABCB1—lymph node—lung cancer	7.74e-05	0.00763	CbGeAlD
Pomalidomide—Constipation—Paclitaxel—lung cancer	7.73e-05	0.000415	CcSEcCtD
Pomalidomide—Pain—Paclitaxel—lung cancer	7.73e-05	0.000415	CcSEcCtD
Pomalidomide—Confusional state—Docetaxel—lung cancer	7.73e-05	0.000415	CcSEcCtD
Pomalidomide—Urinary tract disorder—Methotrexate—lung cancer	7.68e-05	0.000412	CcSEcCtD
Pomalidomide—Weight increased—Doxorubicin—lung cancer	7.65e-05	0.000411	CcSEcCtD
Pomalidomide—Pruritus—Gemcitabine—lung cancer	7.64e-05	0.00041	CcSEcCtD
Pomalidomide—Urethral disorder—Methotrexate—lung cancer	7.62e-05	0.000409	CcSEcCtD
Pomalidomide—Infection—Docetaxel—lung cancer	7.61e-05	0.000409	CcSEcCtD
Pomalidomide—Weight decreased—Doxorubicin—lung cancer	7.61e-05	0.000408	CcSEcCtD
Pomalidomide—Feeling abnormal—Etoposide—lung cancer	7.6e-05	0.000408	CcSEcCtD
Pomalidomide—Hyperglycaemia—Doxorubicin—lung cancer	7.59e-05	0.000407	CcSEcCtD
Pomalidomide—Diarrhoea—Irinotecan—lung cancer	7.58e-05	0.000407	CcSEcCtD
Pomalidomide—Pneumonia—Doxorubicin—lung cancer	7.54e-05	0.000405	CcSEcCtD
Pomalidomide—Nervous system disorder—Docetaxel—lung cancer	7.51e-05	0.000403	CcSEcCtD
Pomalidomide—Thrombocytopenia—Docetaxel—lung cancer	7.5e-05	0.000403	CcSEcCtD
Pomalidomide—Infestation—Doxorubicin—lung cancer	7.5e-05	0.000403	CcSEcCtD
Pomalidomide—Infestation NOS—Doxorubicin—lung cancer	7.5e-05	0.000403	CcSEcCtD
Pomalidomide—Feeling abnormal—Paclitaxel—lung cancer	7.45e-05	0.0004	CcSEcCtD
Pomalidomide—Skin disorder—Docetaxel—lung cancer	7.44e-05	0.0004	CcSEcCtD
Pomalidomide—Hypersensitivity—Cisplatin—lung cancer	7.41e-05	0.000398	CcSEcCtD
Pomalidomide—Diarrhoea—Gemcitabine—lung cancer	7.39e-05	0.000397	CcSEcCtD
Pomalidomide—Renal failure—Doxorubicin—lung cancer	7.37e-05	0.000396	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Doxorubicin—lung cancer	7.35e-05	0.000395	CcSEcCtD
Pomalidomide—Dizziness—Irinotecan—lung cancer	7.33e-05	0.000393	CcSEcCtD
Pomalidomide—Body temperature increased—Etoposide—lung cancer	7.29e-05	0.000391	CcSEcCtD
Pomalidomide—Urinary tract infection—Doxorubicin—lung cancer	7.29e-05	0.000391	CcSEcCtD
Pomalidomide—Asthenia—Cisplatin—lung cancer	7.22e-05	0.000388	CcSEcCtD
Pomalidomide—Cardiac disorder—Methotrexate—lung cancer	7.21e-05	0.000387	CcSEcCtD
Pomalidomide—Body temperature increased—Paclitaxel—lung cancer	7.15e-05	0.000384	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Doxorubicin—lung cancer	7.09e-05	0.000381	CcSEcCtD
Pomalidomide—Epistaxis—Doxorubicin—lung cancer	7.07e-05	0.00038	CcSEcCtD
Pomalidomide—Angiopathy—Methotrexate—lung cancer	7.05e-05	0.000379	CcSEcCtD
Pomalidomide—Vomiting—Irinotecan—lung cancer	7.05e-05	0.000378	CcSEcCtD
Pomalidomide—Mediastinal disorder—Methotrexate—lung cancer	7.01e-05	0.000376	CcSEcCtD
Pomalidomide—Rash—Irinotecan—lung cancer	6.99e-05	0.000375	CcSEcCtD
Pomalidomide—Dermatitis—Irinotecan—lung cancer	6.98e-05	0.000375	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Docetaxel—lung cancer	6.98e-05	0.000375	CcSEcCtD
Pomalidomide—Chills—Methotrexate—lung cancer	6.97e-05	0.000374	CcSEcCtD
Pomalidomide—Headache—Irinotecan—lung cancer	6.94e-05	0.000373	CcSEcCtD
Pomalidomide—Insomnia—Docetaxel—lung cancer	6.93e-05	0.000372	CcSEcCtD
Pomalidomide—Diarrhoea—Cisplatin—lung cancer	6.89e-05	0.00037	CcSEcCtD
Pomalidomide—Vomiting—Gemcitabine—lung cancer	6.87e-05	0.000369	CcSEcCtD
Pomalidomide—Dyspnoea—Docetaxel—lung cancer	6.83e-05	0.000367	CcSEcCtD
Pomalidomide—Mental disorder—Methotrexate—lung cancer	6.81e-05	0.000366	CcSEcCtD
Pomalidomide—Rash—Gemcitabine—lung cancer	6.81e-05	0.000365	CcSEcCtD
Pomalidomide—Dermatitis—Gemcitabine—lung cancer	6.8e-05	0.000365	CcSEcCtD
Pomalidomide—Hypersensitivity—Etoposide—lung cancer	6.79e-05	0.000365	CcSEcCtD
Pomalidomide—Malnutrition—Methotrexate—lung cancer	6.77e-05	0.000363	CcSEcCtD
Pomalidomide—Headache—Gemcitabine—lung cancer	6.76e-05	0.000363	CcSEcCtD
Pomalidomide—Decreased appetite—Docetaxel—lung cancer	6.66e-05	0.000358	CcSEcCtD
Pomalidomide—Hypersensitivity—Paclitaxel—lung cancer	6.66e-05	0.000358	CcSEcCtD
Pomalidomide—Urinary tract disorder—Doxorubicin—lung cancer	6.65e-05	0.000357	CcSEcCtD
Pomalidomide—Oedema peripheral—Doxorubicin—lung cancer	6.63e-05	0.000356	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Docetaxel—lung cancer	6.62e-05	0.000355	CcSEcCtD
Pomalidomide—Asthenia—Etoposide—lung cancer	6.62e-05	0.000355	CcSEcCtD
Pomalidomide—Connective tissue disorder—Doxorubicin—lung cancer	6.61e-05	0.000355	CcSEcCtD
Pomalidomide—Fatigue—Docetaxel—lung cancer	6.61e-05	0.000355	CcSEcCtD
Pomalidomide—Urethral disorder—Doxorubicin—lung cancer	6.6e-05	0.000354	CcSEcCtD
Pomalidomide—Nausea—Irinotecan—lung cancer	6.58e-05	0.000353	CcSEcCtD
Pomalidomide—Pain—Docetaxel—lung cancer	6.55e-05	0.000352	CcSEcCtD
Pomalidomide—Constipation—Docetaxel—lung cancer	6.55e-05	0.000352	CcSEcCtD
Pomalidomide—Back pain—Methotrexate—lung cancer	6.55e-05	0.000351	CcSEcCtD
Pomalidomide—Pruritus—Etoposide—lung cancer	6.52e-05	0.00035	CcSEcCtD
Pomalidomide—Asthenia—Paclitaxel—lung cancer	6.49e-05	0.000348	CcSEcCtD
Pomalidomide—Nausea—Gemcitabine—lung cancer	6.41e-05	0.000344	CcSEcCtD
Pomalidomide—Vomiting—Cisplatin—lung cancer	6.4e-05	0.000344	CcSEcCtD
Pomalidomide—Pruritus—Paclitaxel—lung cancer	6.4e-05	0.000343	CcSEcCtD
Pomalidomide—Rash—Cisplatin—lung cancer	6.35e-05	0.000341	CcSEcCtD
Pomalidomide—Dermatitis—Cisplatin—lung cancer	6.34e-05	0.00034	CcSEcCtD
Pomalidomide—Feeling abnormal—Docetaxel—lung cancer	6.31e-05	0.000339	CcSEcCtD
Pomalidomide—Diarrhoea—Etoposide—lung cancer	6.31e-05	0.000339	CcSEcCtD
Pomalidomide—Anaemia—Methotrexate—lung cancer	6.25e-05	0.000336	CcSEcCtD
Pomalidomide—Cardiac disorder—Doxorubicin—lung cancer	6.25e-05	0.000335	CcSEcCtD
Pomalidomide—Diarrhoea—Paclitaxel—lung cancer	6.19e-05	0.000332	CcSEcCtD
Pomalidomide—Angiopathy—Doxorubicin—lung cancer	6.11e-05	0.000328	CcSEcCtD
Pomalidomide—Dizziness—Etoposide—lung cancer	6.1e-05	0.000327	CcSEcCtD
Pomalidomide—Vertigo—Methotrexate—lung cancer	6.08e-05	0.000326	CcSEcCtD
Pomalidomide—Mediastinal disorder—Doxorubicin—lung cancer	6.07e-05	0.000326	CcSEcCtD
Pomalidomide—Body temperature increased—Docetaxel—lung cancer	6.06e-05	0.000325	CcSEcCtD
Pomalidomide—Leukopenia—Methotrexate—lung cancer	6.06e-05	0.000325	CcSEcCtD
Pomalidomide—Chills—Doxorubicin—lung cancer	6.04e-05	0.000324	CcSEcCtD
Pomalidomide—Dizziness—Paclitaxel—lung cancer	5.98e-05	0.000321	CcSEcCtD
Pomalidomide—Nausea—Cisplatin—lung cancer	5.98e-05	0.000321	CcSEcCtD
Pomalidomide—Cough—Methotrexate—lung cancer	5.9e-05	0.000317	CcSEcCtD
Pomalidomide—Mental disorder—Doxorubicin—lung cancer	5.9e-05	0.000317	CcSEcCtD
Pomalidomide—Vomiting—Etoposide—lung cancer	5.86e-05	0.000315	CcSEcCtD
Pomalidomide—Malnutrition—Doxorubicin—lung cancer	5.86e-05	0.000315	CcSEcCtD
Pomalidomide—Rash—Etoposide—lung cancer	5.81e-05	0.000312	CcSEcCtD
Pomalidomide—Dermatitis—Etoposide—lung cancer	5.81e-05	0.000312	CcSEcCtD
Pomalidomide—Headache—Etoposide—lung cancer	5.78e-05	0.00031	CcSEcCtD
Pomalidomide—Arthralgia—Methotrexate—lung cancer	5.76e-05	0.000309	CcSEcCtD
Pomalidomide—Vomiting—Paclitaxel—lung cancer	5.75e-05	0.000309	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	5.72e-05	0.000307	CcSEcCtD
Pomalidomide—Rash—Paclitaxel—lung cancer	5.7e-05	0.000306	CcSEcCtD
Pomalidomide—Dermatitis—Paclitaxel—lung cancer	5.69e-05	0.000306	CcSEcCtD
Pomalidomide—Back pain—Doxorubicin—lung cancer	5.67e-05	0.000304	CcSEcCtD
Pomalidomide—Headache—Paclitaxel—lung cancer	5.66e-05	0.000304	CcSEcCtD
Pomalidomide—Hypersensitivity—Docetaxel—lung cancer	5.65e-05	0.000303	CcSEcCtD
Pomalidomide—Muscle spasms—Doxorubicin—lung cancer	5.63e-05	0.000302	CcSEcCtD
Pomalidomide—Confusional state—Methotrexate—lung cancer	5.57e-05	0.000299	CcSEcCtD
Pomalidomide—Asthenia—Docetaxel—lung cancer	5.5e-05	0.000295	CcSEcCtD
Pomalidomide—Infection—Methotrexate—lung cancer	5.49e-05	0.000295	CcSEcCtD
Pomalidomide—Nausea—Etoposide—lung cancer	5.48e-05	0.000294	CcSEcCtD
Pomalidomide—Pruritus—Docetaxel—lung cancer	5.42e-05	0.000291	CcSEcCtD
Pomalidomide—Nervous system disorder—Methotrexate—lung cancer	5.42e-05	0.000291	CcSEcCtD
Pomalidomide—Anaemia—Doxorubicin—lung cancer	5.42e-05	0.000291	CcSEcCtD
Pomalidomide—Thrombocytopenia—Methotrexate—lung cancer	5.41e-05	0.00029	CcSEcCtD
Pomalidomide—Nausea—Paclitaxel—lung cancer	5.37e-05	0.000288	CcSEcCtD
Pomalidomide—Skin disorder—Methotrexate—lung cancer	5.36e-05	0.000288	CcSEcCtD
Pomalidomide—Hyperhidrosis—Methotrexate—lung cancer	5.34e-05	0.000287	CcSEcCtD
Pomalidomide—Vertigo—Doxorubicin—lung cancer	5.26e-05	0.000283	CcSEcCtD
Pomalidomide—Leukopenia—Doxorubicin—lung cancer	5.24e-05	0.000282	CcSEcCtD
Pomalidomide—Diarrhoea—Docetaxel—lung cancer	5.24e-05	0.000281	CcSEcCtD
Pomalidomide—Cough—Doxorubicin—lung cancer	5.11e-05	0.000274	CcSEcCtD
Pomalidomide—Dizziness—Docetaxel—lung cancer	5.07e-05	0.000272	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Methotrexate—lung cancer	5.03e-05	0.00027	CcSEcCtD
Pomalidomide—Insomnia—Methotrexate—lung cancer	4.99e-05	0.000268	CcSEcCtD
Pomalidomide—Arthralgia—Doxorubicin—lung cancer	4.99e-05	0.000268	CcSEcCtD
Pomalidomide—Anxiety—Doxorubicin—lung cancer	4.97e-05	0.000267	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	4.95e-05	0.000266	CcSEcCtD
Pomalidomide—Dyspnoea—Methotrexate—lung cancer	4.92e-05	0.000264	CcSEcCtD
Pomalidomide—Vomiting—Docetaxel—lung cancer	4.87e-05	0.000262	CcSEcCtD
Pomalidomide—Rash—Docetaxel—lung cancer	4.83e-05	0.000259	CcSEcCtD
Pomalidomide—Dermatitis—Docetaxel—lung cancer	4.83e-05	0.000259	CcSEcCtD
Pomalidomide—Confusional state—Doxorubicin—lung cancer	4.82e-05	0.000259	CcSEcCtD
Pomalidomide—Decreased appetite—Methotrexate—lung cancer	4.8e-05	0.000258	CcSEcCtD
Pomalidomide—Headache—Docetaxel—lung cancer	4.8e-05	0.000258	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Methotrexate—lung cancer	4.77e-05	0.000256	CcSEcCtD
Pomalidomide—Fatigue—Methotrexate—lung cancer	4.76e-05	0.000256	CcSEcCtD
Pomalidomide—Infection—Doxorubicin—lung cancer	4.75e-05	0.000255	CcSEcCtD
Pomalidomide—Pain—Methotrexate—lung cancer	4.72e-05	0.000254	CcSEcCtD
Pomalidomide—Nervous system disorder—Doxorubicin—lung cancer	4.69e-05	0.000252	CcSEcCtD
Pomalidomide—Thrombocytopenia—Doxorubicin—lung cancer	4.68e-05	0.000251	CcSEcCtD
Pomalidomide—Skin disorder—Doxorubicin—lung cancer	4.64e-05	0.000249	CcSEcCtD
Pomalidomide—Hyperhidrosis—Doxorubicin—lung cancer	4.62e-05	0.000248	CcSEcCtD
Pomalidomide—Nausea—Docetaxel—lung cancer	4.55e-05	0.000244	CcSEcCtD
Pomalidomide—Feeling abnormal—Methotrexate—lung cancer	4.55e-05	0.000244	CcSEcCtD
Pomalidomide—Body temperature increased—Methotrexate—lung cancer	4.37e-05	0.000234	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.36e-05	0.000234	CcSEcCtD
Pomalidomide—Insomnia—Doxorubicin—lung cancer	4.33e-05	0.000232	CcSEcCtD
Pomalidomide—Dyspnoea—Doxorubicin—lung cancer	4.26e-05	0.000229	CcSEcCtD
Pomalidomide—Decreased appetite—Doxorubicin—lung cancer	4.16e-05	0.000223	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Doxorubicin—lung cancer	4.13e-05	0.000222	CcSEcCtD
Pomalidomide—Fatigue—Doxorubicin—lung cancer	4.12e-05	0.000221	CcSEcCtD
Pomalidomide—Pain—Doxorubicin—lung cancer	4.09e-05	0.00022	CcSEcCtD
Pomalidomide—Constipation—Doxorubicin—lung cancer	4.09e-05	0.00022	CcSEcCtD
Pomalidomide—Hypersensitivity—Methotrexate—lung cancer	4.07e-05	0.000218	CcSEcCtD
Pomalidomide—Asthenia—Methotrexate—lung cancer	3.96e-05	0.000213	CcSEcCtD
Pomalidomide—Feeling abnormal—Doxorubicin—lung cancer	3.94e-05	0.000212	CcSEcCtD
Pomalidomide—Pruritus—Methotrexate—lung cancer	3.91e-05	0.00021	CcSEcCtD
Pomalidomide—Body temperature increased—Doxorubicin—lung cancer	3.78e-05	0.000203	CcSEcCtD
Pomalidomide—Diarrhoea—Methotrexate—lung cancer	3.78e-05	0.000203	CcSEcCtD
Pomalidomide—Dizziness—Methotrexate—lung cancer	3.65e-05	0.000196	CcSEcCtD
Pomalidomide—Hypersensitivity—Doxorubicin—lung cancer	3.52e-05	0.000189	CcSEcCtD
Pomalidomide—Vomiting—Methotrexate—lung cancer	3.51e-05	0.000188	CcSEcCtD
Pomalidomide—Rash—Methotrexate—lung cancer	3.48e-05	0.000187	CcSEcCtD
Pomalidomide—Dermatitis—Methotrexate—lung cancer	3.48e-05	0.000187	CcSEcCtD
Pomalidomide—Headache—Methotrexate—lung cancer	3.46e-05	0.000186	CcSEcCtD
Pomalidomide—Asthenia—Doxorubicin—lung cancer	3.43e-05	0.000184	CcSEcCtD
Pomalidomide—Pruritus—Doxorubicin—lung cancer	3.38e-05	0.000182	CcSEcCtD
Pomalidomide—Nausea—Methotrexate—lung cancer	3.28e-05	0.000176	CcSEcCtD
Pomalidomide—Diarrhoea—Doxorubicin—lung cancer	3.27e-05	0.000176	CcSEcCtD
Pomalidomide—Dizziness—Doxorubicin—lung cancer	3.16e-05	0.00017	CcSEcCtD
Pomalidomide—Vomiting—Doxorubicin—lung cancer	3.04e-05	0.000163	CcSEcCtD
Pomalidomide—Rash—Doxorubicin—lung cancer	3.02e-05	0.000162	CcSEcCtD
Pomalidomide—Dermatitis—Doxorubicin—lung cancer	3.01e-05	0.000162	CcSEcCtD
Pomalidomide—Headache—Doxorubicin—lung cancer	3e-05	0.000161	CcSEcCtD
Pomalidomide—Nausea—Doxorubicin—lung cancer	2.84e-05	0.000152	CcSEcCtD
Pomalidomide—ABCB1—Metabolism—GSTA3—lung cancer	1.31e-05	0.000138	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTM2—lung cancer	1.29e-05	0.000137	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CNDP2—lung cancer	1.29e-05	0.000137	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.29e-05	0.000137	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCG2—lung cancer	1.28e-05	0.000135	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ADCY1—lung cancer	1.28e-05	0.000135	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APP—lung cancer	1.26e-05	0.000134	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MTMR3—lung cancer	1.26e-05	0.000133	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—EGFR—lung cancer	1.26e-05	0.000133	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FGF9—lung cancer	1.25e-05	0.000133	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ENO2—lung cancer	1.25e-05	0.000133	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HPGDS—lung cancer	1.25e-05	0.000133	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLBD1—lung cancer	1.25e-05	0.000132	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.25e-05	0.000132	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPP2R1B—lung cancer	1.25e-05	0.000132	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.24e-05	0.000131	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.23e-05	0.00013	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—B4GALT5—lung cancer	1.23e-05	0.00013	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PGAM1—lung cancer	1.23e-05	0.00013	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTT1—lung cancer	1.22e-05	0.000129	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.21e-05	0.000128	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP2A6—lung cancer	1.2e-05	0.000127	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GCLC—lung cancer	1.2e-05	0.000127	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—JUNB—lung cancer	1.2e-05	0.000127	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.2e-05	0.000127	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTA4—lung cancer	1.2e-05	0.000126	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—KRAS—lung cancer	1.19e-05	0.000126	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.18e-05	0.000125	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.18e-05	0.000125	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2A7—lung cancer	1.17e-05	0.000124	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTA2—lung cancer	1.16e-05	0.000123	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SDC4—lung cancer	1.15e-05	0.000121	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HSD17B10—lung cancer	1.14e-05	0.000121	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ENO1—lung cancer	1.14e-05	0.00012	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.13e-05	0.00012	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTA1—lung cancer	1.12e-05	0.000119	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.12e-05	0.000118	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.11e-05	0.000118	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ABCC3—lung cancer	1.11e-05	0.000118	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AKR1C1—lung cancer	1.08e-05	0.000114	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CKB—lung cancer	1.06e-05	0.000112	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FOXO3—lung cancer	1.05e-05	0.000111	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—UGT1A1—lung cancer	1.04e-05	0.000111	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—RRM1—lung cancer	1.04e-05	0.00011	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTA3—lung cancer	1.04e-05	0.00011	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.02e-05	0.000108	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP2E1—lung cancer	1.02e-05	0.000108	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NQO1—lung cancer	1.01e-05	0.000107	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—HRAS—lung cancer	1.01e-05	0.000107	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GNG11—lung cancer	1.01e-05	0.000107	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTM2—lung cancer	9.99e-06	0.000106	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CNDP2—lung cancer	9.99e-06	0.000106	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	9.9e-06	0.000105	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.89e-06	0.000105	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—B4GALT5—lung cancer	9.81e-06	0.000104	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MTMR3—lung cancer	9.72e-06	0.000103	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6—lung cancer	9.67e-06	0.000102	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALDOA—lung cancer	9.59e-06	0.000101	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTA4—lung cancer	9.54e-06	0.000101	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	9.53e-06	0.000101	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PGAM1—lung cancer	9.47e-06	0.0001	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	9.33e-06	9.86e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NCOA3—lung cancer	9.31e-06	9.85e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTA2—lung cancer	9.3e-06	9.84e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HES1—lung cancer	9.3e-06	9.83e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—STK11—lung cancer	9.1e-06	9.63e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ABCG2—lung cancer	9.06e-06	9.58e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ADCY1—lung cancer	9.06e-06	9.58e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2A7—lung cancer	9.03e-06	9.56e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTA1—lung cancer	8.97e-06	9.49e-05	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—AKT1—lung cancer	8.92e-06	9.43e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ENO2—lung cancer	8.88e-06	9.4e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HPGDS—lung cancer	8.88e-06	9.4e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCC3—lung cancer	8.87e-06	9.38e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SDC4—lung cancer	8.84e-06	9.35e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPP2R1B—lung cancer	8.83e-06	9.34e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ERCC2—lung cancer	8.69e-06	9.19e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTT1—lung cancer	8.62e-06	9.11e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AKR1C1—lung cancer	8.59e-06	9.09e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.55e-06	9.04e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GCLC—lung cancer	8.52e-06	9.01e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2A6—lung cancer	8.52e-06	9.01e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ERBB3—lung cancer	8.5e-06	8.99e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTP1—lung cancer	8.42e-06	8.91e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	8.36e-06	8.84e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—UGT1A1—lung cancer	8.34e-06	8.82e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CAT—lung cancer	8.2e-06	8.67e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.15e-06	8.62e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TERT—lung cancer	8.15e-06	8.62e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ENO1—lung cancer	8.07e-06	8.54e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	8.07e-06	8.53e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTA3—lung cancer	8.05e-06	8.52e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—RRM1—lung cancer	8.05e-06	8.52e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GNG11—lung cancer	8.04e-06	8.51e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	8e-06	8.46e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCB1—lung cancer	7.97e-06	8.44e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FGFR1—lung cancer	7.91e-06	8.37e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—TYMS—lung cancer	7.83e-06	8.28e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HIF1A—lung cancer	7.79e-06	8.24e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTM1—lung cancer	7.74e-06	8.19e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALDOA—lung cancer	7.66e-06	8.1e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—B4GALT5—lung cancer	7.57e-06	8.01e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	7.55e-06	7.99e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOA1—lung cancer	7.52e-06	7.95e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NCOA3—lung cancer	7.43e-06	7.86e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTA4—lung cancer	7.36e-06	7.79e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP1A1—lung cancer	7.34e-06	7.76e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	7.3e-06	7.73e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ERCC2—lung cancer	7.28e-06	7.7e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2E1—lung cancer	7.24e-06	7.66e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ADCY1—lung cancer	7.23e-06	7.65e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCG2—lung cancer	7.23e-06	7.65e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTA2—lung cancer	7.18e-06	7.59e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NQO1—lung cancer	7.16e-06	7.57e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HPGDS—lung cancer	7.09e-06	7.5e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ENO2—lung cancer	7.09e-06	7.5e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPP2R1B—lung cancer	7.05e-06	7.45e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.95e-06	7.35e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTA1—lung cancer	6.92e-06	7.32e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTT1—lung cancer	6.88e-06	7.28e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—KIT—lung cancer	6.86e-06	7.26e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APC—lung cancer	6.86e-06	7.26e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCC3—lung cancer	6.85e-06	7.24e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	6.83e-06	7.22e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GCLC—lung cancer	6.8e-06	7.19e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2A6—lung cancer	6.8e-06	7.19e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—EGF—lung cancer	6.78e-06	7.18e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.77e-06	7.16e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AKR1C1—lung cancer	6.63e-06	7.01e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—STK11—lung cancer	6.45e-06	6.83e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—BRAF—lung cancer	6.45e-06	6.82e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ENO1—lung cancer	6.44e-06	6.82e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—UGT1A1—lung cancer	6.44e-06	6.81e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.42e-06	6.79e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6R—lung cancer	6.37e-06	6.74e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CREBBP—lung cancer	6.36e-06	6.73e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.34e-06	6.71e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOA1—lung cancer	6.3e-06	6.66e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GNG11—lung cancer	6.21e-06	6.57e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MAP2K1—lung cancer	6.07e-06	6.43e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PIK3CD—lung cancer	6.03e-06	6.38e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.03e-06	6.38e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTP1—lung cancer	5.97e-06	6.32e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALDOA—lung cancer	5.91e-06	6.25e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CAT—lung cancer	5.81e-06	6.15e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2E1—lung cancer	5.78e-06	6.11e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CG—lung cancer	5.75e-06	6.08e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NCOA3—lung cancer	5.74e-06	6.07e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NQO1—lung cancer	5.72e-06	6.05e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.6e-06	5.92e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADCY1—lung cancer	5.58e-06	5.9e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCG2—lung cancer	5.58e-06	5.9e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TYMS—lung cancer	5.55e-06	5.87e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.55e-06	5.87e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTM1—lung cancer	5.49e-06	5.8e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HPGDS—lung cancer	5.47e-06	5.79e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ENO2—lung cancer	5.47e-06	5.79e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—POMC—lung cancer	5.47e-06	5.79e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.44e-06	5.75e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MDM2—lung cancer	5.41e-06	5.72e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—RAF1—lung cancer	5.39e-06	5.7e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CREBBP—lung cancer	5.33e-06	5.64e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ERBB2—lung cancer	5.33e-06	5.64e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTT1—lung cancer	5.31e-06	5.61e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MTOR—lung cancer	5.26e-06	5.56e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PIK3CB—lung cancer	5.26e-06	5.56e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CD4—lung cancer	5.25e-06	5.55e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GCLC—lung cancer	5.25e-06	5.55e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2A6—lung cancer	5.25e-06	5.55e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP1A1—lung cancer	5.2e-06	5.5e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ERCC2—lung cancer	5.16e-06	5.46e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—STK11—lung cancer	5.15e-06	5.45e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CD—lung cancer	5.05e-06	5.35e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALB—lung cancer	4.99e-06	5.28e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ENO1—lung cancer	4.97e-06	5.26e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.84e-06	5.12e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTP1—lung cancer	4.77e-06	5.04e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CAT—lung cancer	4.64e-06	4.91e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.61e-06	4.88e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CDKN1A—lung cancer	4.56e-06	4.82e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PTEN—lung cancer	4.54e-06	4.81e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCB1—lung cancer	4.51e-06	4.77e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOA1—lung cancer	4.46e-06	4.72e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2E1—lung cancer	4.46e-06	4.72e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TYMS—lung cancer	4.43e-06	4.69e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NQO1—lung cancer	4.41e-06	4.67e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CB—lung cancer	4.4e-06	4.66e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTM1—lung cancer	4.38e-06	4.63e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—EP300—lung cancer	4.33e-06	4.58e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SRC—lung cancer	4.21e-06	4.46e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP1A1—lung cancer	4.15e-06	4.39e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ERCC2—lung cancer	4.12e-06	4.36e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CG—lung cancer	4.07e-06	4.31e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—STAT3—lung cancer	4.06e-06	4.3e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NRAS—lung cancer	4.05e-06	4.29e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—STK11—lung cancer	3.98e-06	4.21e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MAPK3—lung cancer	3.88e-06	4.11e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—POMC—lung cancer	3.88e-06	4.1e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PTEN—lung cancer	3.81e-06	4.03e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CREBBP—lung cancer	3.78e-06	4e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MYC—lung cancer	3.78e-06	4e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—EGFR—lung cancer	3.69e-06	3.91e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTP1—lung cancer	3.68e-06	3.89e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—EP300—lung cancer	3.63e-06	3.84e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CD—lung cancer	3.58e-06	3.79e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CAT—lung cancer	3.58e-06	3.79e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOA1—lung cancer	3.56e-06	3.77e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALB—lung cancer	3.54e-06	3.74e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—KRAS—lung cancer	3.49e-06	3.69e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCB1—lung cancer	3.48e-06	3.68e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TYMS—lung cancer	3.42e-06	3.62e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.41e-06	3.61e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTM1—lung cancer	3.38e-06	3.58e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CG—lung cancer	3.25e-06	3.44e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PIK3CA—lung cancer	3.21e-06	3.39e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP1A1—lung cancer	3.21e-06	3.39e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ERCC2—lung cancer	3.18e-06	3.36e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CB—lung cancer	3.12e-06	3.3e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—POMC—lung cancer	3.1e-06	3.28e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS2—lung cancer	3.09e-06	3.27e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CREBBP—lung cancer	3.02e-06	3.19e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HRAS—lung cancer	2.97e-06	3.14e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CD—lung cancer	2.86e-06	3.02e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6—lung cancer	2.84e-06	3e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALB—lung cancer	2.82e-06	2.99e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOA1—lung cancer	2.75e-06	2.91e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTEN—lung cancer	2.7e-06	2.85e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CA—lung cancer	2.69e-06	2.84e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKT1—lung cancer	2.62e-06	2.77e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—EP300—lung cancer	2.57e-06	2.72e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CG—lung cancer	2.51e-06	2.66e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CB—lung cancer	2.49e-06	2.64e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS2—lung cancer	2.47e-06	2.61e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—POMC—lung cancer	2.39e-06	2.53e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CREBBP—lung cancer	2.33e-06	2.46e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CD—lung cancer	2.21e-06	2.33e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AKT1—lung cancer	2.19e-06	2.32e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALB—lung cancer	2.18e-06	2.3e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTEN—lung cancer	2.15e-06	2.28e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—EP300—lung cancer	2.05e-06	2.17e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CB—lung cancer	1.92e-06	2.03e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS2—lung cancer	1.91e-06	2.02e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CA—lung cancer	1.9e-06	2.01e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTEN—lung cancer	1.66e-06	1.76e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—EP300—lung cancer	1.59e-06	1.68e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AKT1—lung cancer	1.55e-06	1.64e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CA—lung cancer	1.52e-06	1.61e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AKT1—lung cancer	1.24e-06	1.31e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CA—lung cancer	1.17e-06	1.24e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AKT1—lung cancer	9.58e-07	1.01e-05	CbGpPWpGaD
